By Alexandra Sifferlin and Heather Jones
August 18, 2015
TIME Health
For more, visit TIME Health.

The first drug to treat a lack of female sexual desire has been approved by federal authorities.

The drug flibanserin, which has been coined ‘female Viagra,’ is intended to treat women with a condition called hypoactive sexual desire disorder (HSDD) that’s characterized by lagging libido. On Tuesday, the drug was approved by the U.S. Food and Drug Administration. “Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

Although the drug is being called a “Viagra” for women, it actually works quite differently. You can see how below.

Heather Jones for TIME

Read next: What 8 Medical Experts Think About ‘Female Viagra’

Download TIME’s mobile app for iOS to have your world explained wherever you go

SPONSORED FINANCIAL CONTENT

You May Like

EDIT POST